Acquisition Speculation Fuels Viking Therapeutics Stock Surge
Published on 10/11/2025 at 20:27 | Redaktion boerse-global.de
Shares of Viking Therapeutics experienced significant upward momentum, climbing 8.1% to reach $33.90 amid renewed market speculation about potential acquisition activity in the obesity treatment sector. Investor enthusiasm was clearly demonstrated through trading volume that surged 47% above average levels, reaching 4.4 million shares.
The biotech firm has demonstrated impressive performance in recent weeks, accumulating gains exceeding 15% and hitting an intraday peak of $35.45 during the latest session. This upward movement has elevated the company’s market capitalization to approximately $3.8 billion as market participants position themselves ahead of the scheduled October 22 release of third-quarter financial results.
Recent strategic moves within the pharmaceutical industry have intensified acquisition discussions. Two substantial transactions have particularly captured market attention: Novo Nordisk’s $5.2 billion purchase of Akero Therapeutics and... Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
